Foodborne Diseases Treatment Market Segments, Drivers And Trends 2022
The global foodborne diseases treatment market size was valued at USD X billion in 2021 and is poised to grow at a significant CAGR of X% during the forecast period 2022-28. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on “Foodborne Diseases Treatment Market by drug class (Antibiotics, Anti Diarrhea, Fluids and Electrolyte Replenishers, Vaccines, Others), disease( Botulism, Traveler’s Diarrhea, Gastroenteritis, Toxoplasmosis, Others), route of administration (Parenteral, Oral, Others), distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. Drug Stores) and Geography (North America, Latin America, Europe, Asia Pacific and Middle East and Africa) - Global/Region/Country Forecast to 2028”.
View detailed report description at https://precisionbusinessinsights.com/market-reports/global-foodborne-diseases-treatment-market/
Growing R&D investment is fuelling the Foodborne Diseases Treatment Market:
Foodborne diseases cover a huge range of sicknesses, which affect the people globally. Such sicknesses occur because of the intake of food contaminated with harmful microorganisms or chemicals. The contamination occurs from soil, water or air. The most common foodborne infections are caused due to three bacteria salmonella, campylobacter and E.coli and by a group of viruses named calicivirus. Abdominal pain, vomiting and diarrhea are a few of the symptoms of foodborne diseases. Clinical symptoms of foodborne diseases are seen in gastro intestinal tract. In a few cases these diseases can also have immunological, neurological and gynecological and a few other symptoms. Traveler’s diarrhea, hepatitis, tapeworm infection, botulism and salmonellosis are common foodborne diseases. Increasing cases of foodborne disease globally is the most important factor fuels the global foodborne diseases market.
There are several factors that drive the foodborne diseases treatment market such as increasing R&D investment, dearth of hygiene conditions and growing consciousness regarding foodborne disease symptoms because of the initiatives of government and non-government organizations like WHO. On the other hand, time-consuming regulatory procedures and the high cost of R&D investment for developing anti microbial are anticipated to hamper the foodborne diseases market.
Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=15725
North America dominates the Foodborne Diseases Treatment Market
On the basis of geographical analysis, foodborne disease treatment market has been categorized into different regions such as Europe, North America, Latin America, Middle East, Africa and Asia Pacific. North America foodborne diseases treatment market is anticipated to value at noteworthy rates because of the increase in the occurrence of foodborne diseases including toxoplasmosis and botulism and growing R&D investment by companies on vaccines and antibiotics. Africa and Asia Pacific regions are projecting profitable opportunity for foodbourne diseases treatment market due to increase in the occurrence of foodborne illnesses in such regions. South East Asia and Africa regions have the highest cases and death rates, including children under age of 5 years. Europe is anticipated to reveal considerable growth rate because of the increasing healthcare spending and R&D investment.
The global foodborne diseases treatment market key players are Bayer AG (Germany), Johnson & Johnson Services Inc., (U.S.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), XOMA Corporation (U.S.), AlphaVax, Inc. (U.S.), Molecular Targeting Technologies, Inc. (U.S.) and Morphotek Inc. (U.S.). Key players focus on following major collaborations and mergers like strategies.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian